Navigation Links
InspireMD Secures Financing to Accelerate Advancements in Product Development and Adopts a One Year Stockholder Rights Plan
Date:10/24/2013

s, (v) product liability claims, (vi) our limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) our reliance on single suppliers for certain product components, (xi) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Transition Report on Form 10-K/T and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
Phone: 212-896-1215 / 212-896-1250
Email: tfromer@kcsa.com / grussell@kcsa.com

Media Contacts:
'/>"/>

SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. InspireMD To Participate In Benchmark Investor Conference On May 30th
2. InspireMD Hires Vice President of Corporate Development
3. Michael Berman Joins InspireMD Board
4. InspireMD Postpones $40 Million Registered
5. InspireMD Reports 2012 Fiscal Year Results
6. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
7. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
8. InspireMD Appoints Dr. James Barry to Its Board of Directors
9. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
10. Apexigen Secures $20 Million Series A1 Financing
11. GlycoVaxyn AG secures CHF 5.1 million Strategic Translation Award from the Wellcome Trust to finance clinical development of Shigella vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... The report “Adipic Acid Market by Application, ... Trends & Forecast to 2019” report analyzes the ... opportunities, and trends in different regions. , Browse ... through 217 slides and in-depth TOC on “Adipic ... 2019”., http://www.marketsandmarkets.com/Market-Reports/adipic-acid-269.html , Early buyers will receive ...
(Date:10/25/2014)... ViaDerma, Inc (OTCQB: ... to bringing new products to market, is committed ... has developed an innovative, patent-pending dual carrier transdermal ... of pharmaceutical active ingredients to penetrate the skin ... therapy. The transdermal delivery method also overcomes microbial ...
(Date:10/25/2014)... York, NY (PRWEB) October 23, 2014 ... announced the winners for the 2014 BioProcess International ... business strategies, social corporate responsibility and technology applications ... more effective treatments to a global patient base. ... by their peers during a very entertaining and ...
(Date:10/25/2014)... According to new market research report ... (Colocation, Enterprise, Telecom), by Design Types (Electrical, Mechanical), ... Tier 3, Tier 4) - Global Forecast to ... Data Center Construction Market into various segments with ... research report also identifies the factors driving this ...
Breaking Biology Technology:Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 2Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 3Adipic Acid Market Estimated to Grow $7,539.2 Million by 2019 - Report by MarketsandMarkets 4ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 2Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 4
... ANNAPOLIS, Md. , Jan. 26 The following ... CEO of PharmAthene, regarding the Commission on the Prevention of ... Today,s Report Card by the Commission on the Prevention of ... warning that America still remains vulnerable to bioterrorism.  Our Nation,s ...
... , SHANGHAI , ... pharmaceutical R&D outsourcing Service Company in China , announced,that ... visited Sundia on January 22, 2010 . M.Raffarin, ... Serge,Feneuille and Mr. Erwan Davoux of ...
... , , , , ... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ("3SBio" or "the Company"), ... and marketing,biopharmaceutical products, today announced that it will release financial,results for ... 8:00 PM (Eastern) on, Thursday, February 11, 2010 . , ...
Cached Biology Technology:Former French Prime Minister Jean-Pierre Raffarin Visits Sundia 23SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010 2
(Date:10/25/2014)... Oct.  22, 2014   MedNet Solutions , a ... management systems, is pleased to announce the 2014 ... – to be held in Bloomington, Minnesota ... to have record attendance and promises to be informative, ... The focus of the meeting is iMedNet™ ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 This ... is a relatively new space in heavy pursuit of ... are unique to miRNAs compared to other RNA components. ... make it a novel candidate for use as a ... pursuit of miRNA-based microarrays and diagnostics for the advancement ...
(Date:10/25/2014)... LONDON , Oct. 22, 2014 A ... in-depth analysis of the current and future genetic testing ... principles and types are covered in this report. On ... market trends; drivers; and existing strengths and challenges; forecast ... the market is likely to grow at a CAGR ...
Breaking Biology News(10 mins):MedNet Solutions To Host Third Annual iMedNet User Group Meeting 2MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Genetic Testing Market Outlook 2018 2
... pain more than men despite the popular notion that the ... differences in pain have found that not only do women ... also experience it in more bodily areas, more often and ... seem to be differences in how men and women think ...
... base are the guinea pigs for Oak Ridge National ... better determine whether a species has vanished. , After ... biologists were a bit concerned and were looking for ... ecologist and member of ORNL's Environmental Sciences Division. A ...
... a newly released method to analyze functional magnetic ... that the interconnections between different parts of the ... other findings answer longstanding debates about how brain ... are presented in the current (June 1) issue ...
Cached Biology News:Women feel more pain than men, research shows 2Women feel more pain than men, research shows 3Elusive salamanders have role in developing new sampling models 2Elusive salamanders have role in developing new sampling models 3Brain networks change according to cognitive task 2Brain networks change according to cognitive task 3